U.S. Postmaster General Megan J. Brennan has dedicated a new semipostal stamp to fund research to find a cure…
Articles by Ana de Barros, PhD
Otsuka Pharmaceutical announced that it and Lundbeck will launch a third Phase 3 clinical trial of brexpiprazole to possibly treat agitation in…
A first-of-its-kind event, “A Women’s Health Summit: It Starts With the Brain,” set for today in New York, will focus…
The Alzheimer’s Association and Alzheimer’s Drug Discovery Foundation will fund a Phase 2 clinical trial of a combination therapy…
The U.S. Food and Drug Administration (FDA) has placed CT1812 on fast track as a potential treatment of patients with Alzheimer’s…
Ionis Pharmaceuticals has started a Phase 1/2 clinical trial to evaluate the Alzheimer’s therapy IONIS-MAPTRx. IONIS-MAPTRx is aimed at reducing the…
Acadia Pharmaceuticals is starting its Phase 3 HARMONY trial to evaluate Nuplazid (pimavanserin) as a treatment for hallucinations and delusions…
UsAgainstAlzheimer’s released a report showing that Alzheimer’s disease is both an urgent healthcare concern among older U.S. military…
It’s easy to forget — or be reluctant — to take family photographs when a member of the family is…
A researcher at the Jackson Laboratory (JAX) in Maine has been awarded a five-year, $5.4 million grant to investigate why genetic mutations linked to …